Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3779755 Target Snapshot

NACHT, LRR and PYD domains-containing protein 3 · SINGLE PROTEIN · Mus musculus

646Compounds
393Assays
5Approved Drugs
530.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8R4B8. Use UniProt Q8R4B8 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8R4B8 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NACHT, LRR and PYD domains-containing protein 3 as ChEMBL target CHEMBL3779755, mapped to UniProt Q8R4B8. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NACHT, LRR and PYD domains-containing protein 3
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL3779755
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8R4B8
NACHT, LRR and PYD domains-containing protein 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NACHT, LRR and PYD domains-containing protein 3 is the right protein anchor across sources, using UniProt Q8R4B8 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNACHT, LRR and PYD domains-containing protein 3
UniProt AccessionQ8R4B8
Component TypeProtein
Sequence Length1033 aa

NACHT, LRR and PYD domains-containing protein 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NACHT, LRR and PYD domains-containing protein 3, mapped to UniProt Q8R4B8. Sequence length is 1033 aa.

Mapped IDQ8R4B8
Review nameNACHT, LRR and PYD domains-containing protein 3
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

5
Approved
4
Phase III
2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50528.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5184952 9.64 IC50 0.23 Preclinical
CHEMBL3183703 9.41 IC50 0.39 Preclinical
CHEMBL3989943 9.0 IC50 1.0 Clinical
CHEMBL5421905 8.16 IC50 6.88 Preclinical
CHEMBL4288808 8.1 IC50 8.0 Preclinical
CHEMBL5422387 8.07 IC50 8.58 Preclinical
CHEMBL4650350 7.85 IC50 14.0 Preclinical
CHEMBL5396485 7.85 IC50 14.0 Preclinical
CHEMBL5597392 7.82 IC50 15.29 Preclinical
CHEMBL5436366 7.7 IC50 19.9 Preclinical
Distribution

pChEMBL Value Distribution

80
5.0
113
5.5
82
6.0
51
6.5
30
7.0
14
7.5
12
8.0
0
8.5
3
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

393
Total Assays
432
Tested Compounds
1
Assay Types
Binding — 393 assays, 432 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 285 361 6.0
tissue-based format 45 46 5.2
single protein format 30 20 6.0
subcellular format 24 0
assay format 9 5 6.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine